Circulating tumor DNA in biliary tract cancers: challenges, opportunities, and clinical readiness
Trends in Cancer · 2026-07 · 12 (7) · 575-579
DOI: 10.1016/j.trecan.2026.05.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2026-07. Verfasst von Francheska Cadacio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Biliary Tract Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: España Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III, Ikerbasque, Basque Foundation for Science.
Abstract (Originalsprache)
Biliary tract cancers have a poor prognosis, with tumor location and desmoplasia often restricting tissue acquisition for molecular profiling. Circulating tumor DNA is a minimally invasive alternative with expanding clinical utility, although technical and standardization challenges limit its routine adoption. We review evidence, limitations, and strategies supporting large-scale validation for real-time monitoring and personalized treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain.
- Medical Oncology Department, Lille University-UMR9020 CNRS-U1366 INSERM-CHU de Lille, Lille 59000, France.
- Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; National Institute for the Study…
- Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain; Clínic Barcelona Comprehensive Cancer Center (4CB), Barcelona, Spain; Translational Oncology in Upper Gastrointestinal Cancer Group, August…
- Department of Medical Oncology - OncoHealth Institute, Fundacion Jimenez Diaz University Hospital, Madrid, Spain; Health Research Institute-Fundación Jimenez Diaz University Hospital (IIS-FJD), Madrid, Spain; Universida…
- Department of Medical Oncology, UCL Cancer Institute, London, UK.
Förderung
- España Ministerio de Ciencia e Innovación
- Instituto de Salud Carlos III
- Ikerbasque, Basque Foundation for Science
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- Fundación Fero
- Spanish Association Against Cancer Scientific Foundation
- European Cooperation in Science and Technology
Zitieren
APA
Cadacio, F., Turpin, A., Rodrigues, P. M., Castet, F., Lamarca, A., Bridgewater, J., Bañales, J. M., Macarulla, T., & Tian, T. V. (2026). Circulating tumor DNA in biliary tract cancers: challenges, opportunities, and clinical readiness. Trends in Cancer, 12(7), 575-579. https://doi.org/10.1016/j.trecan.2026.05.002
Vancouver
Cadacio F, Turpin A, Rodrigues PM, Castet F, Lamarca A, Bridgewater J, et al. Circulating tumor DNA in biliary tract cancers: challenges, opportunities, and clinical readiness. Trends in Cancer. 2026;12(7):575-579. doi:10.1016/j.trecan.2026.05.002
BibTeX
@article{Cadacio2026,
author = {Cadacio, Francheska and Turpin, Anthony and Rodrigues, Pedro M and Castet, Florian and Lamarca, Angela and Bridgewater, John and Bañales, Jesús M and Macarulla, Teresa and Tian, Tian V},
title = {Circulating tumor DNA in biliary tract cancers: challenges, opportunities, and clinical readiness},
journal = {Trends in Cancer},
year = {2026},
volume = {12},
number = {7},
pages = {575--579},
doi = {10.1016/j.trecan.2026.05.002}
}
EUVIMED